Literature DB >> 7369302

Abnormalities of the pupil and visual-evoked potential in quinine amblyopia.

J L Gangitano, J L Keltner.   

Abstract

Total blindness with a transient tonic pupillary response, denervation supersensitivity, and abnormal visual-evoked potentials developed in a 54-year-old man after the use of quinine sulfate for leg cramps. He later recovered normal visual acuity. A transient tonic pupillary response, denervation supersensitivity, and abnormal visual-evoked potentials in quinine toxicity, to our knowledge, have not been previously reported.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7369302     DOI: 10.1016/0002-9394(80)90015-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

1.  The management of quinine-induced blindness.

Authors:  U Guly; P Driscoll
Journal:  Arch Emerg Med       Date:  1992-09

2.  Ocular quinine toxicity.

Authors:  C R Canning; S Hague
Journal:  Br J Ophthalmol       Date:  1988-01       Impact factor: 4.638

3.  Ocular toxicity from systemic drug therapy. An overview of clinically important adverse reactions.

Authors:  S I Davidson; I G Rennie
Journal:  Med Toxicol       Date:  1986 May-Jun

4.  Examination of the fast oscillation of the corneoretinal potential under clinical conditions.

Authors:  N Rohde; R Täumer; H Bleckmann
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

Review 5.  Blindness from quinine toxicity.

Authors:  P Bacon; D J Spalton; S E Smith
Journal:  Br J Ophthalmol       Date:  1988-03       Impact factor: 4.638

6.  Death and blindness due to overdose of quinine.

Authors:  E H Dyson; A T Proudfoot; L F Prescott; R Heyworth
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-06

Review 7.  Clinically important ocular reactions to systemic drug therapy.

Authors:  I G Rennie
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.